摘要
目的优化我院处方前置审核系统并评价其应用效果。方法针对系统运行初期规则库不完善、假阳性率高等问题,通过完善多维度规则库、调整拦截等级及提示方式、优化审方药师工作模式、加强临床沟通等措施对系统进行多维度优化。采用回顾性研究,以我院2023年6-12月处方数据为对照组(优化前),2024年6-12月处方数据为观察组(优化后),通过组间对比分析,评价处方前置审核系统优化的实际效果。结果处方合格率从优化前的(82.51±4.04)%升高至优化后的(90.98±1.55)%,假阳性率从优化前的(20.87±1.64)%降至优化后的(7.41±2.04)%。处方合格率的月间极差由10.24%降至4.11%,变异系数由4.92%降至1.73%;假阳性率的月间极差由4.40%略增至5.34%,变异系数由8.32%升高至26.18%。结论通过对我院处方前置审核系统进行多维度优化,其处方审核效能显著提升,处方质量稳定提高,审核精准度显著改善。
OBJECTIVE To optimize the prescription pre-review system in our hospital and evaluate its application effects.METHODS Aiming at the problems of imperfect rule base and high false positive rate in the early operation of the system,optimization measures were taken,including improving the content of the rule base,adjusting the interception level and prompt mode,refining the working model of prescription review pharmacists,and strengthening clinical communication.A retrospective cohort study was conducted,with prescription data from June to December 2023(before optimization)as the control group and June to December 2024(after optimization)as the observation group.Through inter group comparative analysis,the actual effect of optimizing the prescription pre-approval system was evaluated.RESULTS The prescription qualified rate increased from(82.51±4.04)%before optimization to(90.98±1.55)%after optimization;the false positive rate decreased from(20.87±1.64)%before optimization to(7.41±2.04)%after optimization.The monthly range of prescription qualified rate narrowed from 10.24%to 4.11%,and the coefficient of variation decreased from 4.92%to 1.73%.The monthly range of false positive rate slightly increased from 4.40%to 5.34%,the coefficient of variation rose from 8.32%to 26.18%.CONCLUSIONS Through multi-dimensional optimizations of the prescription pre-review system in our hospital,its prescription review efficiency has been significantly enhanced,the quality of prescriptions has steadily improved,and the accuracy of reviews has notably improved.
作者
高广明
刘天娇
徐娜
梁晶
孙向菊
朱战国
闫虹
GAO Guangming;LIU Tianjiao;XU Na;LIANG Jing;SUN Xiangju;ZHU Zhanguo;YAN Hong(Dept.of Clinical Pharmacy,the Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China)
出处
《中国药房》
北大核心
2025年第14期1797-1801,共5页
China Pharmacy
基金
中国药学会科普研究重点项目(No.CMEI2024KPYJ00618)。
关键词
处方前置审核
规则库
优化策略
合理用药
临床药师
处方
prescription pre-review
rule base
optimization strategy
rational drug use
clinical pharmacist
prescription
